Paxlovid API Market, Global Outlook and Forecast 2022-2028
The global Paxlovid API market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028. The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028. Purity 99% Segment to Reach $ Million by 2028, with a % CAGR in next six years. Report Sample includes: - Table of Contents - List of Tables & Figures - Charts - Research Methodology Get FREE Sample of this Report at https://www.24marketreports.com/report-sample/global-paxlovid-api-forecast-2022-2028-901 The global key manufacturers of Paxlovid API include Pfizer, Nanjing Hicin Pharmaceutical, Lepu Medical, HAS Biotech and Novasep, etc. In 2021, the global top five players have a share approximately % in terms of revenue. MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Paxlovid API manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, produc...